Katherine L. Wisner, MD, MS | Psychiatrist.com

MDD and Bipolar Disorder in Black and White Postpartum Women

Original Research

MDD and Bipolar Disorder in Black and White Postpartum Women

November 20, 2024

No significant difference was observed in the rate of postpartum MDD in Black (40%) versus white (35%) women. However, bipolar disorder significantly differed between Black (19.2%) and white (11.5%)...

Taylor N. Burchfield , Amy Yang , Katherine L. Wisner , et al

Pharmacogenetic Phenotypes in a Perinatal Mental Health Clinic

Original Research

Pharmacogenetic Phenotypes in a Perinatal Mental Health Clinic

June 10, 2024

In patients of childbearing age who have had atypical responses or side effects to antidepressants, pharmacogenomic testing may be considered to guide dose or choice of agent. Dose adjustments...

Jessica L. W. Mayer , Hannah K. Betcher , Laura J. Rasmussen-Torvik , et al

Original Research

Methadone and QTc in Pregnancy

September 26, 2017

When clinicians use methadone as the standard treatment for opioid-dependent pregnant women, must they be concerned about its effects on the heart of mother and child? Read this study...

Debra L. Bogen , Barbara H. Hanusa , James M. Perel , et al

Original Research

Telephone-Based Postpartum Depression Care Management

August 8, 2017

Depression occurs in nearly 22% of new mothers within the year after the birth. Telephone care management could offer a flexible and efficient way to reach out to these...

Katherine L. Wisner , Dorothy K. Y. Sit , Mary McShea , et al

Article

Neonatal Discontinuation Syndrome in SRI-Exposed Infants

May 24, 2017

When treating a pregnant woman with SRIs, one area of concern relates to discontinuation symptoms that may occur in the infant. This study explored whether prematurity, SRI exposure, or...

Amy Yang , Jody D. Ciolino , Emily Pinheiro , et al

Original Research

Developmental Outcomes of Infants of Mothers With Bipolar Disorder

January 3, 2017

The risks of medication for bipolar disorder during pregnancy must be weighed carefully against the risks of untreated illness. Find out whether exposure to maternal illness and/or to medication...

Aimee K. Santucci , Lynn T. Singer , Stephen R. Wisniewski , et al

Academic Highlights

Impact of Prenatal Exposure to Psychotropic Drugs on Neonatal Outcome in Infants of Mothers With Serious Psychiatric Illnesses

July 22, 2015

Anne-Laure Sutter-Dallay , Mélanie Bales , Elodie Pambrun , et al

Academic Highlights

Impact of Prenatal Exposure to Serotonin Reuptake Inhibitors or Maternal Major Depressive Disorder on Infant Developmental Outcomes

October 28, 2014

Aimee K. Santucci , Lynn T. Singer , Stephen R. Wisniewski , et al

Article

Mother-Infant Antidepressant Concentrations, Maternal Depression, and Perinatal Events

July 15, 2011

Dorothy Sit , James M. Perel , Stephen R. Wisniewski , et al

Article

Light Therapy for Antepartum Depression

April 5, 2011

Read a study on Light Therapy for Antepartum Depression and the promising pilot trials from a randomized, double-blind, placebo-controlled study.

Anna Wirz-Justice , Anja Bader , Ulrike Frisch , et al

Article

Are Maternal Depression or Symptom Severity Associated With Breastfeeding Intention or Outcomes?

June 15, 2010

Debra L. Bogen , Barbara H. Hanusa , Eydie Moses-Kolko , et al

Original Research

Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Report

June 15, 2010

Marlene P. Freeman , Maurizio Fava , James Lake , et al

1 2 3 »